Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer

被引:9
|
作者
Kurowska, Natalia [1 ]
Madej, Marcel [1 ,2 ]
Strzalka-Mrozik, Barbara [1 ]
机构
[1] Med Univ Siles, Fac Pharmaceut Sci Sosnowiec, Dept Mol Biol, PL-40055 Katowice, Poland
[2] Med Univ Silesia, Ctr Res & Implementat, Siles LabMed, PL-40752 Katowice, Poland
关键词
Nigella sativa; thymoquinone; colorectal cancer; adjuvant therapy; anticancer therapy; 5-FU resistance; NIGELLA-SATIVA L; LOVO COLON-CANCER; ANTICANCER THYMOQUINONE; OXIDATIVE STRESS; CELL-DEATH; APOPTOSIS; EXTRACTION; 5-FLUOROURACIL; INHIBITION; SEEDS;
D O I
10.3390/cimb46010010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and is responsible for approximately one million deaths each year. The current standard of care is surgical resection of the lesion and chemotherapy with 5-fluorouracil (5-FU). However, of concern is the increasing incidence in an increasingly younger patient population and the ability of CRC cells to develop resistance to 5-FU. In this review, we discuss the effects of thymoquinone (TQ), one of the main bioactive components of Nigella sativa seeds, on CRC, with a particular focus on the use of TQ in combination therapy with other chemotherapeutic agents. TQ exhibits anti-CRC activity by inducing a proapoptotic effect and inhibiting proliferation, primarily through its effect on the regulation of signaling pathways crucial for tumor progression and oxidative stress. TQ can be used synergistically with chemotherapeutic agents to enhance their anticancer effects and to influence the expression of signaling pathways and other genes important in cancer development. These data appear to be most relevant for co-treatment with 5-FU. We believe that TQ is a suitable candidate for consideration in the chemoprevention and adjuvant therapy for CRC, but further studies, including clinical trials, are needed to confirm its safety and efficacy in the treatment of cancer.
引用
收藏
页码:121 / 139
页数:19
相关论文
共 50 条
  • [2] Thymoquinone: a promising antidiabetic agent
    Majed M. AbuKhader
    International Journal of Diabetes in Developing Countries, 2012, 32 : 65 - 68
  • [3] Thymoquinone: a promising antidiabetic agent
    AbuKhader, Majed M.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2012, 32 (02) : 65 - 68
  • [4] Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials
    Krasteva, Natalia
    Georgieva, Milena
    PHARMACEUTICS, 2022, 14 (06)
  • [5] Cinobufagin: a promising therapeutic agent for cancer
    Dai, Chun-Lan
    Zhang, Run-jing
    An, Pei
    Deng, Yi-Qing
    Rahman, Khalid
    Zhang, Hong
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2023, 75 (09) : 1141 - 1153
  • [6] sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment
    Huang, Ying
    Li, Xihan
    Sha, Huizi
    Zhang, Lianru
    Bian, Xinyu
    Han, Xiao
    Liu, Baorui
    SCIENTIFIC REPORTS, 2017, 7
  • [7] Melittin fromApis floreaVenom as a Promising Therapeutic Agent for Skin Cancer Treatment
    Sangboonruang, Sirikwan
    Kitidee, Kuntida
    Chantawannakul, Panuwan
    Tragoolpua, Khajornsak
    Tragoolpua, Yingmanee
    ANTIBIOTICS-BASEL, 2020, 9 (08): : 1 - 18
  • [8] Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment
    Kao, Aaron T.
    V. Cabanlong, Christian
    Padilla, Kendra
    Xue, Xiang
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (09) : 3785 - 3801
  • [9] sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment
    Ying Huang
    Xihan Li
    Huizi Sha
    Lianru Zhang
    Xinyu Bian
    Xiao Han
    Baorui Liu
    Scientific Reports, 7
  • [10] Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Colorectal Cancer
    Shapira, Shiran
    Pelban, Shlomo
    Arber, Nadir
    GASTROENTEROLOGY, 2015, 148 (04) : S14 - S14